Skip to main content
Kent Academic Repository

Browse by Person (creator, editor, contributor, etc.)

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Jump to: Article
Number of items: 2.

Article

Walton, M. I. and Eve, P. D. and Hayes, A. and Valenti, M. R. and De Haven Brandon, A. K. and Box, G. and Hallsworth, A. and Smith, E. L. and Boxall, K. J. and Lainchbury, M. and Matthews, T. P. and Jamin, Y. and Robinson, S. P. and Aherne, G. W. and Reader, J. C. and Chesler, L. and Raynaud, F. I. and Eccles, S. A. and Collins, I. and Garrett, Michelle D. (2012) CCT244747 Is a Novel Potent and Selective CHK1 Inhibitor with Oral Efficacy Alone and in Combination with Genotoxic Anticancer Drugs. Clinical Cancer Research, 18 (20). pp. 5650-5661. ISSN 1078-0432. (doi:https://doi.org/10.1158/1078-0432.CCR-12-1322) (The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided)

Yap, T. A. and Walton, M. I. and Grimshaw, K. M. and te Poele, R. H. and Eve, P. D. and Valenti, M. R. and de Haven Brandon, A. K. and Martins, V. and Zetterlund, A. and Heaton, S. P. and Heinzmann, K. and Jones, P. S. and Feltell, R. E. and Reule, M. and Woodhead, S. J. and Davies, T. G. and Lyons, J. F. and Raynaud, F. I. and Eccles, S. A. and Workman, P. and Thompson, N. T. and Garrett, Michelle D. (2012) AT13148 Is a Novel, Oral Multi-AGC Kinase Inhibitor with Potent Pharmacodynamic and Antitumor Activity. Clinical Cancer Research, 18 (14). pp. 3912-3923. ISSN 1078-0432. (doi:https://doi.org/10.1158/1078-0432.CCR-11-3313) (The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided)

This list was generated on Mon May 13 09:39:14 2019 BST.